Print ISSN:-2395-1354

Online ISSN:-2395-1362

CODEN : IJOSHC

Article History

Received : 02-09-2022

Accepted : 15-09-2022



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 429

PDF Downloaded: 251


A comparative study of one day versus three days peri-operative use of prophylactic antibiotics in orthopedic surgery


Full Text PDF


Original Article

Author Details : Nareshkumar Satyanarayan Dhaniwala*, Mukund Naresh Dhaniwala, Rameez Bukhari, Parth S Shah

Volume : 8, Issue : 3, Year : 2022

Article Page : 222-225

https://doi.org/10.18231/j.ijos.2022.039



Suggest article by email

Get Permission

Abstract

Prophylactic systemic antibiotics is the standard practice to prevent surgical site infections in orthopedic surgery including arthroplasty. There is enough evidence showing its utility in preventing or reducing surgical site infection. Timing of administration, antibiotics to be used and duration of antibiotics are controversial points regarding this practice. The present study using Ceftriaxone 1 gram intravenously 3 doses during 24 hours peri-operative period (group 1 n =58) versus 3 days (group 2 n= 57) has been carried out on planned orthopedic surgeries with specific exclusion and followed up for 1 year. None of the cases of either group developed any infection. The study demonstrates the utility of antibiotics prophylaxis and is a step in deciding guidelines about antibiotics use in our country.
 

Keywords: Antibiotics, Prophylaxis, Infection, Orthopedic surgery.



How to cite : Dhaniwala N S, Dhaniwala M N, Bukhari R, Shah P S, A comparative study of one day versus three days peri-operative use of prophylactic antibiotics in orthopedic surgery. Indian J Orthop Surg 2022;8(3):222-225


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.